{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:32:33Z","timestamp":1779892353029,"version":"3.53.1"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10462-x","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T13:26:36Z","timestamp":1744118796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current nano drug delivery systems for targeting head and neck squamous cell carcinoma microenvironment: a narrative review"],"prefix":"10.1007","volume":"52","author":[{"given":"Aref","family":"Faraji-Barhagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Jahandar-Lashaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Jahanban","family":"Esfahlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effat","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"issue":"1","key":"10462_CR1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR (2020) Head and neck squamous cell carcinoma. Nat Rev Dis Primers 6(1):92","journal-title":"Nat Rev Dis Primers"},{"key":"10462_CR2","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin","DOI":"10.3322\/caac.21834"},{"issue":"1","key":"10462_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41392-022-01297-0","volume":"8","author":"Q Li","year":"2023","unstructured":"Li Q, Tie Y, Alu A, Ma X, Shi H (2023) Targeted therapy for head and neck cancer: signaling pathways and clinical studies. Signal Transduct Target Ther 8(1):31","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10462_CR4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41416-019-0602-7","volume":"122","author":"ME Sabatini","year":"2020","unstructured":"Sabatini ME, Chiocca S (2020) Human papillomavirus as a driver of head and neck cancers. Br J Cancer 122(3):306\u2013314","journal-title":"Br J Cancer"},{"key":"10462_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fonc.2018.00257","volume":"8","author":"Q Fernandes","year":"2018","unstructured":"Fernandes Q, Merhi M, Raza A, Inchakalody VP, Abdelouahab N, Zar Gul AR, Uddin S, Dermime S (2018) Role of Epstein-Barr virus in the pathogenesis of head and neck cancers and its potential as an immunotherapeutic target. Front Oncol 8:257","journal-title":"Front Oncol"},{"key":"10462_CR6","doi-asserted-by":"crossref","unstructured":"Amaral MN, Fa\u00edsca P, Ferreira HA, Gaspar MM, Reis CP (2022) Current insights and progress in the clinical management of head and neck cancer. Cancers (Basel) 14(24)","DOI":"10.3390\/cancers14246079"},{"key":"10462_CR7","doi-asserted-by":"crossref","unstructured":"Wang CW, Biswas PK, Islam A, Chen MK, Chueh PJ (2024) The use of immune regulation in treating head and neck squamous cell carcinoma (HNSCC). Cells 13(5)","DOI":"10.3390\/cells13050413"},{"issue":"5","key":"10462_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188784","volume":"1877","author":"A Jangholi","year":"2022","unstructured":"Jangholi A, M\u00fcller Bark J, Kenny L, Vasani S, Rao S, Dolcetti R, Punyadeera C (2022) Exosomes at the crossroad between therapeutic targets and therapy resistance in head and neck squamous cell carcinoma. Biochim Biophys Acta Rev Cancer 1877(5):188784","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"24","key":"10462_CR9","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.7314\/APJCP.2014.15.24.10705","volume":"15","author":"MM Abbasi","year":"2014","unstructured":"Abbasi MM, Jahanban-Esfahlan R, Monfaredan A, Seidi K, Hamishehkar H, Khiavi MM (2014) Oral and IV dosages of doxorubicin-methotrexate loaded\u2014nanoparticles inhibit progression of oral cancer by down\u2014regulation of matrix methaloproteinase 2 expression in vivo. Asian Pac J Cancer Prev APJCP 15(24):10705\u201310711","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10462_CR10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116951","volume":"177","author":"S Alimohammadvand","year":"2024","unstructured":"Alimohammadvand S, Kaveh Zenjanab M, Mashinchian M, Shayegh J, Jahanban-Esfahlan R (2024) Recent advances in biomimetic cell membrane\u2013camouflaged nanoparticles for cancer therapy. Biomed Pharmacother 177:116951","journal-title":"Biomed Pharmacother"},{"key":"10462_CR11","doi-asserted-by":"crossref","unstructured":"Dadashi H, Mashinchian M, Karimian-Shaddel A, Mohabbat A, Vandghanooni S, Eskandani M, Jahanban-Esfahlan R (2024) Chitosan nanoparticles loaded with metformin and digoxin synergistically inhibit MCF-7 breast cancer cells through suppression of NOTCH-1 and HIF-1\u03b1 gene expression. Int J Biol Macromol 138418","DOI":"10.1016\/j.ijbiomac.2024.138418"},{"issue":"5","key":"10462_CR12","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ad5d9b","volume":"19","author":"M Sharifi-Azad","year":"2024","unstructured":"Sharifi-Azad M, Kaveh Zenjanab M, Shahpouri M, Adili-Aghdam MA, Fathi M, Jahanban-Esfahlan R (2024) Codelivery of methotrexate and silibinin by niosome nanoparticles for enhanced chemotherapy of CT26 colon cancer cells. Biomed Mater 19(5):055015","journal-title":"Biomed Mater"},{"key":"10462_CR13","volume":"31","author":"S Karimi","year":"2025","unstructured":"Karimi S, Bakhshali R, Bolandi S, Zahed Z, Mojtaba Zadeh SS, Kaveh Zenjanab M, Jahanban Esfahlan R (2025) For and against tumor microenvironment: nanoparticle-based strategies for active cancer therapy. Mater Today Biol 31:101626","journal-title":"Mater Today Biol"},{"key":"10462_CR14","doi-asserted-by":"crossref","unstructured":"Mazloomi M, Doustmihan A, Alimohammadvand S, Hamishehkar H, Hamblin MR, Esfahlan RJ (2025) Advanced drug delivery platforms target cancer stem cells. Asian J Pharm Sci 101036","DOI":"10.1016\/j.ajps.2025.101036"},{"issue":"3","key":"10462_CR15","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/jcp.25859","volume":"233","author":"R Jahanban-Esfahlan","year":"2017","unstructured":"Jahanban-Esfahlan R, de la Guardia M, Ahmadi D, Yousefi B (2017) Modulating tumor hypoxia by nanomedicine for effective cancer therapy. J Cell Physiol 233(3):2019\u20132031","journal-title":"J Cell Physiol"},{"key":"10462_CR16","volume":"95","author":"M Kaveh Zenjanab","year":"2024","unstructured":"Kaveh Zenjanab M, Alimohammadvand S, Doustmihan A, Kianian S, Sadeghzadeh Oskouei B, Mazloomi M, Akbari M, Jahanban-Esfahlan R (2024) Paclitaxel for breast cancer therapy: a review on effective drug combination modalities and nano drug delivery platforms. J Drug Deliv Sci Technol 95:105567","journal-title":"J Drug Deliv Sci Technol"},{"issue":"196","key":"10462_CR17","first-page":"1","volume":"22","author":"M Sharifi-Azad","year":"2022","unstructured":"Sharifi-Azad M, Fathi M, Cho WC, Barzegari A, Dadashi H, Dadashpour M, Jahanban-Esfahlan R (2022) Recent advances in targeted drug delivery systems for resistant colorectal cancer. Cancer Cell Int 22(196):1\u201321","journal-title":"Cancer Cell Int"},{"key":"10462_CR18","volume":"30","author":"H Derakhshankhah","year":"2022","unstructured":"Derakhshankhah H, Haghshenas B, Eskandani M, Jahanban-Esfahlan R, Abbasi-Maleki S, Jaymand M (2022) Folate-conjugated thermal- and pH-responsive magnetic hydrogel as a drug delivery nano-system for \u201csmart\u201d chemo\/hyperthermia therapy of solid tumors. Mater Today Commun 30:103148","journal-title":"Mater Today Commun"},{"issue":"1","key":"10462_CR19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/pat.5082","volume":"32","author":"S Sayadnia","year":"2021","unstructured":"Sayadnia S, Arkan E, Jahanban-Esfahlan R, Sayadnia S, Jaymand M (2021) Tragacanth gum-based pH-responsive magnetic hydrogels for \u201csmart\u201d chemo\/hyperthermia therapy of solid tumors. Polym Adv Technol 32(1):262\u2013271","journal-title":"Polym Adv Technol"},{"key":"10462_CR20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1557\/s43578-021-00137-1","volume":"36","author":"R Jahanban-Esfahlan","year":"2021","unstructured":"Jahanban-Esfahlan R, Soleimani K, Derakhshankhah H, Haghshenas B, Rezaei A, Massoumi B, Farnudiyan-Habibi A, Samadian H, Jaymand M (2021) Multi-stimuli-responsive magnetic hydrogel based on Tragacanth gum as a de novo nanosystem for targeted chemo\/hyperthermia treatment of cancer. J Mater Res 36:858\u2013869","journal-title":"J Mater Res"},{"key":"10462_CR21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2018.08.043","volume":"288","author":"H Dianat-Moghadam","year":"2018","unstructured":"Dianat-Moghadam H, Heydarifard M, Jahanban-Esfahlan R, Panahi Y, Hamishehkar H, Pouremamali F, Rahbarghazi R, Nouri M (2018) Cancer stem cells-emanated therapy resistance: implications for liposomal drug delivery systems. J Control Release 288:62\u201383","journal-title":"J Control Release"},{"issue":"9","key":"10462_CR22","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1021\/acsomega.3c09782","volume":"9","author":"M Kaveh Zenjanab","year":"2024","unstructured":"Kaveh Zenjanab M, Abdolahinia ED, Alizadeh E, Hamishehkar H, Shahbazi R, Ranjbar-Navazi Z, Jahanban-Esfahlan R, Fathi M, Mohammadi SA (2024) Hyaluronic acid-targeted niosomes for effective breast cancer chemostarvation therapy. ACS Omega 9(9):10875\u201310885","journal-title":"ACS Omega"},{"issue":"1","key":"10462_CR23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12668-024-01647-y","volume":"15","author":"Z Hashemi","year":"2024","unstructured":"Hashemi Z, Beheshtizadeh N, Jaymand M, Jahanban-Esfahlan A, Akbari M, Jahanban Esfahlan R (2024) Engineered niosomes for cancer therapy: classification, synthesis, and clinical applications. BioNanoScience 15(1):34","journal-title":"BioNanoScience"},{"issue":"1","key":"10462_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11033-025-10241-8","volume":"52","author":"M Fakeri","year":"2025","unstructured":"Fakeri M, Haghi M, Jahanban Esfahlan R, Fathi M, Hosseinpour Feizi MA (2025) Targeted apoptosis in breast cancer cells via niosome-mediated delivery of cyclophosphamide and sodium oxamate. Mol Biol Rep 52(1):139","journal-title":"Mol Biol Rep"},{"key":"10462_CR25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jconrel.2019.10.003","volume":"315","author":"A Jahanban-Esfahlan","year":"2019","unstructured":"Jahanban-Esfahlan A, Seidi K, Jaymand M, Schmidt TL, Zare P, Javaheri T, Jahanban-Esfahlan R (2019) Dynamic DNA nanostructures in biomedicine: beauty, utility and limits. J Control Release 315:166\u2013185","journal-title":"J Control Release"},{"issue":"12","key":"10462_CR26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/NSA.S227193","volume":"2019","author":"R Jahanban-Esfahlan","year":"2019","unstructured":"Jahanban-Esfahlan R, Seidi K, Jahanban-Esfahlan A, Jaymand M, Alizadeh E, Majdi H, Najjar R, Javaheri T, Zare P (2019) Static DNA nanostructures for cancer theranostics: recent progress in design and applications. Nannotechnology Sci Appl 2019(12):25\u201346","journal-title":"Nannotechnology Sci Appl"},{"key":"10462_CR27","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ijbiomac.2019.10.086","volume":"147","author":"B Massoumi","year":"2020","unstructured":"Massoumi B, Abbasian M, Jahanban-Esfahlan R, Mohammad-Rezaei R, Khalilzadeh B, Samadian H, Rezaei A, Derakhshankhah H, Jaymand M (2020) A novel bio-inspired conductive, biocompatible, and adhesive terpolymer based on polyaniline, polydopamine, and polylactide as scaffolding biomaterial for tissue engineering application. Int J Biol Macromol 147:1174\u20131184","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"10462_CR28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pi.5987","volume":"69","author":"B Massoumi","year":"2020","unstructured":"Massoumi B, Abbasian M, Jahanban-Esfahlan R, Motamedi S, Samadian H, Rezaei A, Derakhshankhah H, Farnudiyan-Habibi A, Jaymand M (2020) PEGylated hollow pH-responsive polymeric nanocapsules for controlled drug delivery. J Polym Int 69(5):519\u2013527","journal-title":"J Polym Int"},{"key":"10462_CR29","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101157","volume":"39","author":"K Seidi","year":"2021","unstructured":"Seidi K, Ayoubi-Joshaghani MH, Azizi M, Javaheri T, Jaymand M, Alizadeh E, Webster TJ, Yazdi AA, Niazi M, Hamblin MR et al (2021) Bioinspired hydrogels build a bridge from bench to bedside. Nano Today 39:101157","journal-title":"Nano Today"},{"issue":"4","key":"10462_CR30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1557\/jmr.2020.3","volume":"35","author":"H Samadian","year":"2020","unstructured":"Samadian H, Mohammad-Rezaei R, Jahanban-Esfahlan R, Massoumi B, Abbasian M, Jafarizad A, Jaymand M (2020) A de novo theranostic nanomedicine composed of PEGylated graphene oxide and gold nanoparticles for cancer therapy. J Mater Res 35(4):430\u2013441","journal-title":"J Mater Res"},{"issue":"11","key":"10462_CR31","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32183","volume":"10","author":"M Eskandani","year":"2024","unstructured":"Eskandani M, Jahanban-Esfahlan R, Sadughi MM, Jaymand M (2024) Thermal-responsive \u03b2-cyclodextrin-based magnetic hydrogel as a de novo nanomedicine for chemo\/hyperthermia treatment of cancerous cells. Heliyon 10(11):e32183","journal-title":"Heliyon"},{"key":"10462_CR32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ijbiomac.2020.04.074","volume":"156","author":"R Jahanban-Esfahlan","year":"2020","unstructured":"Jahanban-Esfahlan R, Derakhshankhah H, Haghshenas B, Massoumi B, Abbasian M, Jaymand M (2020) A bio-inspired magnetic natural hydrogel containing gelatin and alginate as a drug delivery system for cancer chemotherapy. Int J Biol Macromol 156:438\u2013445","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"10462_CR33","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.31557\/APJCP.2023.24.6.2089","volume":"24","author":"T Nayerpour Dizaj","year":"2023","unstructured":"Nayerpour Dizaj T, Jafari-Gharabaghlou D, Farhoudi Sefidan Jadid M, Jahanban R, Rahimi M, Farajollahi MM, Mohsenzadegan M, Zarghami N (2023) Fabrication of antibody conjugated super magnetic oxide nanoparticles for early detection of prostate cancer. Asian Pac J Cancer Prevent APJCP 24(6):2089\u20132097","journal-title":"Asian Pac J Cancer Prevent APJCP"},{"key":"10462_CR34","doi-asserted-by":"crossref","unstructured":"Zhao C, Song W, Wang J, Tang X, Jiang Z (2025) Immunoadjuvant-functionalized metal-organic frameworks: synthesis and applications in tumor immune modulation. Chem Commun","DOI":"10.1039\/D4CC06510G"},{"key":"10462_CR35","doi-asserted-by":"crossref","unstructured":"Moshrefiravasjani R, Kamrani A, Nazari N, Jafari F, Nasiri H, Jahanban-esfahlan R, Akbari M (2024) Exosome-mediated tumor metastasis: biology, molecular targets and immuno-therapeutic options. Pathol Res Pract 155083","DOI":"10.1016\/j.prp.2023.155083"},{"key":"10462_CR36","doi-asserted-by":"crossref","unstructured":"Omrani M, Beyrampour-Basmenj H, Jahanban-Esfahlan R, Talebi M, Raeisi M, Serej ZA, Akbar-Gharalari N, Khodakarimi S, Wu J, Ebrahimi-kalan A (2023) Global trend in exosome isolation and application: an update concept in management of diseases. Mol Cell Biochem","DOI":"10.1007\/s11010-023-04756-6"},{"key":"10462_CR37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2023.09.029","volume":"363","author":"A Doustmihan","year":"2023","unstructured":"Doustmihan A, Fathi M, Mazloomi M, Salemi A, Hamblin MR, Jahanban-Esfahlan R (2023) Molecular targets, therapeutic agents and multitasking nanoparticles to deal with cancer stem cells: a narrative review. J Control Release 363:57\u201383","journal-title":"J Control Release"},{"key":"10462_CR38","doi-asserted-by":"crossref","unstructured":"Mahmudi H, Adili-Aghdam MA, Shahpouri M, Jaymand M, Amoozgar Z, Jahanban-Esfahlan R (2022) Tumor microenvironment penetrating chitosan nanoparticles for elimination of cancer relapse and minimal residual disease. Front Oncol 12","DOI":"10.3389\/fonc.2022.1054029"},{"key":"10462_CR39","doi-asserted-by":"crossref","first-page":"13339","DOI":"10.2147\/IJN.S486465","volume":"19","author":"D Zhang","year":"2024","unstructured":"Zhang D, Song J, Jing Z, Qin H, Wu Y, Zhou J, Zang X (2024) Stimulus responsive nanocarrier for enhanced antitumor responses against hepatocellular carcinoma. Int J Nanomedicine 19:13339\u201313355","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10462_CR40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12943-019-0983-5","volume":"18","author":"B Peltanova","year":"2019","unstructured":"Peltanova B, Raudenska M, Masarik M (2019) Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer 18(1):63","journal-title":"Mol Cancer"},{"issue":"1","key":"10462_CR41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-020-00419-w","volume":"6","author":"AA Bhat","year":"2021","unstructured":"Bhat AA, Yousuf P, Wani NA, Rizwan A, Chauhan SS, Siddiqi MA, Bedognetti D, El-Rifai W, Frenneaux MP, Batra SK et al (2021) Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. Signal Transduct Target Ther 6(1):12","journal-title":"Signal Transduct Target Ther"},{"key":"10462_CR42","doi-asserted-by":"crossref","first-page":"100672","DOI":"10.1016\/j.mtbio.2023.100672","volume":"20","author":"M Azizi","year":"2023","unstructured":"Azizi M, Jahanban-Esfahlan R, Samadian H, Hamidi M, Seidi K, Dolatshahi-Pirouz A, Yazdi AA, Shavandi A, Laurent S, Be Omide Hagh M et al (2023) Multifunctional nanostructures: intelligent design to overcome biological barriers. Mater Today Biol 20:100672","journal-title":"Mater Today Biol"},{"issue":"1","key":"10462_CR43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T, Zare P (2020) Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal 18(1):59","journal-title":"Cell Commun Signal"},{"issue":"8","key":"10462_CR44","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/cancers11081207","volume":"11","author":"R Jahanban-Esfahlan","year":"2019","unstructured":"Jahanban-Esfahlan R, Seidi K, Manjili MH, Jahanban-Esfahlan A, Javaheri T, Zare P (2019) Tumor cell dormancy: threat or opportunity in the fight against cancer. Cancers 11(8):1207","journal-title":"Cancers"},{"issue":"1","key":"10462_CR45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41368-021-00131-7","volume":"13","author":"A Elmusrati","year":"2021","unstructured":"Elmusrati A, Wang J, Wang CY (2021) Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma. Int J Oral Sci 13(1):24","journal-title":"Int J Oral Sci"},{"issue":"6","key":"10462_CR46","volume":"11","author":"HS Rad","year":"2022","unstructured":"Rad HS, Shiravand Y, Radfar P, Ladwa R, Perry C, Han X, Warkiani ME, Adams MN, Hughes BG, O\u2019Byrne K et al (2022) Understanding the tumor microenvironment in head and neck squamous cell carcinoma. Clin Transl Immunol 11(6):e1397","journal-title":"Clin Transl Immunol"},{"issue":"1\u20133","key":"10462_CR47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12026-012-8306-6","volume":"54","author":"CC Tong","year":"2012","unstructured":"Tong CC, Kao J, Sikora AG (2012) Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer. Immunol Res 54(1\u20133):266\u2013274","journal-title":"Immunol Res"},{"issue":"45","key":"10462_CR48","doi-asserted-by":"crossref","first-page":"2004098","DOI":"10.1002\/adfm.202004098","volume":"30","author":"MH Ayoubi-Joshaghani","year":"2020","unstructured":"Ayoubi-Joshaghani MH, Seidi K, Azizi M, Jaymand M, Javaheri T, Jahanban-Esfahlan R, Hamblin MR (2020) Potential applications of advanced nano\/hydrogels in biomedicine: static, dynamic, multi-stage, and bioinspired. Adv Funct Mater 30(45):2004098","journal-title":"Adv Funct Mater"},{"key":"10462_CR49","volume":"82","author":"H Dadashi","year":"2023","unstructured":"Dadashi H, Eskandani M, Roshangar L, Sharifi-Azad M, Shahpouri M, Cho WC, Jahanban-Esfahlan R (2023) Remotely-controlled hydrogel platforms for recurrent cancer therapy. J Drug Deliv Sci Technol 82:104354","journal-title":"J Drug Deliv Sci Technol"},{"key":"10462_CR50","doi-asserted-by":"crossref","first-page":"1189323","DOI":"10.3389\/fimmu.2023.1189323","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Dong P, Yang L (2023) The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment. Front Immunol 14:1189323","journal-title":"Front Immunol"},{"issue":"7","key":"10462_CR51","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1158\/1535-7163.MCT-20-0252","volume":"20","author":"A Lindemann","year":"2021","unstructured":"Lindemann A, Patel AA, Tang L, Tanaka N, Gleber-Netto FO, Bartels MD, Wang L, McGrail DJ, Lin S-Y, Frank SJ (2021) Combined inhibition of Rad51 and Wee1 enhances cell killing in HNSCC through induction of apoptosis associated With excessive DNA damage and replication StressB02 and AZD1775 potentiate cell killing in HNSCC. Mol Cancer Ther 20(7):1257\u20131269","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10462_CR52","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10616-012-9452-3","volume":"64","author":"K Nejati-Koshki","year":"2012","unstructured":"Nejati-Koshki K, Zarghami N, Pourhassan-Moghaddam M, Rahmati-Yamchi M, Mollazade M, Nasiri M, Esfahlan RJ, Barkhordari A, Tayefi-Nasrabadi H (2012) Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors. Cytotechnology 64(6):719\u2013726","journal-title":"Cytotechnology"},{"key":"10462_CR53","doi-asserted-by":"publisher","DOI":"10.34172\/apb.2024.035","author":"MK Zenjanab","year":"2024","unstructured":"Zenjanab MK, Hashemzadeh N, Alimohammadvand S, SharifiAzad M, Abdolahinia ED, Jahanban-Esfahlan R (2024) Notch signaling suppression by golden phytochemicals: potential for cancer therapy. Adv Pharm Bull. https:\/\/doi.org\/10.34172\/apb.2024.035","journal-title":"Adv Pharm Bull"},{"key":"10462_CR54","doi-asserted-by":"crossref","DOI":"10.1201\/b11185","volume-title":"Anticancer agents from natural products","author":"GM Cragg","year":"2011","unstructured":"Cragg GM, Kingston DG, Newman DJ (2011) Anticancer agents from natural products. CRC press, Boca Raton"},{"issue":"1","key":"10462_CR55","first-page":"1","volume":"48","author":"F Zhu","year":"2021","unstructured":"Zhu F, Li X, Tang X, Jiang J, Han Y, Li Y, Ma C, Liu Z, He Y (2021) Neferine promotes the apoptosis of HNSCC through the accumulation of p62\/SQSTM1 caused by autophagic flux inhibition. Int J Mol Med 48(1):1\u201312","journal-title":"Int J Mol Med"},{"key":"10462_CR56","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106304","volume":"137","author":"PP Argyris","year":"2023","unstructured":"Argyris PP, Saavedra F, Malz C, Stone IA, Wei Y, Boyle WS, Johnstone KF, Khammanivong A, Herzberg MC (2023) Intracellular calprotectin (S100A8\/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma. Oral Oncol 137:106304","journal-title":"Oral Oncol"},{"issue":"18","key":"10462_CR57","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1158\/1078-0432.CCR-19-0096","volume":"25","author":"A Lindemann","year":"2019","unstructured":"Lindemann A, Patel AA, Silver NL, Tang L, Liu Z, Wang L, Tanaka N, Rao X, Takahashi H, Maduka NK (2019) COTI-2, A novel thiosemicarbazone derivative, exhibits antitumor activity in HNSCC through p53-dependent and-independent MechanismsCOTI-2 synergizes with Cisplatin and radiation in HNSCC. Clin Cancer Res 25(18):5650\u20135662","journal-title":"Clin Cancer Res"},{"key":"10462_CR58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2019.02.052","volume":"451","author":"W Yang","year":"2019","unstructured":"Yang W, Jiang C, Xia W, Ju H, Jin S, Liu S, Zhang L, Ren G, Ma H, Ruan M et al (2019) Blocking autophagy flux promotes interferon-alpha-mediated apoptosis in head and neck squamous cell carcinoma. Cancer Lett 451:34\u201347","journal-title":"Cancer Lett"},{"key":"10462_CR59","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang L, Yao C, Ma Y, Liu Y (2022) Epithelial membrane protein 1 promotes sensitivity to RSL3-induced ferroptosis and intensifies gefitinib resistance in head and neck cancer. Oxidative Med Cell Longev 2022","DOI":"10.1155\/2022\/4750671"},{"issue":"9","key":"10462_CR60","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.3390\/cancers12092371","volume":"12","author":"M Bernard","year":"2020","unstructured":"Bernard M, Cardin GB, Cahuzac M, Ayad T, Bissada E, Guertin L, Bahig H, Nguyen-Tan PF, Filion E, Ballivy O (2020) Dual inhibition of autophagy and PI3K\/AKT\/MTOR pathway as a therapeutic strategy in head and neck squamous cell carcinoma. Cancers 12(9):2371","journal-title":"Cancers"},{"key":"10462_CR61","volume":"231","author":"K Xue","year":"2019","unstructured":"Xue K, Li J, Nan S, Zhao X, Xu C (2019) Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206. Life Sci 231:116459","journal-title":"Life Sci"},{"key":"10462_CR62","doi-asserted-by":"crossref","unstructured":"Duah E, Seligson ND, Persaud AK, Dam Q, Pabla N, Rocco JW, Li J, Poi M (2023) CDK4\/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas. Mol Carcinog","DOI":"10.1002\/mc.23556"},{"issue":"1","key":"10462_CR63","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1080\/10717544.2021.1923863","volume":"28","author":"J Riestra-Ayora","year":"2021","unstructured":"Riestra-Ayora J, S\u00e1nchez-Rodr\u00edguez C, Palao-Suay R, Yanes-D\u00edaz J, Mart\u00edn-Hita A, Aguilar MR, Sanz-Fern\u00e1ndez R (2021) Paclitaxel-loaded polymeric nanoparticles based on \u03b1-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma: in vivo murine model. Drug Deliv 28(1):1376\u20131388","journal-title":"Drug Deliv"},{"key":"10462_CR64","volume":"423","author":"X Zhang","year":"2021","unstructured":"Zhang X, Yang S, Wang Q, Ye W, Liu S, Wang X, Zhang Z, Cao L, Jiang X (2021) Tailored theranostic nanoparticles cause efficient ferroptosis in head and neck squamous cell carcinoma through a reactive oxygen species \u201cbutterfly effect.\u201d Chem Eng J 423:130083","journal-title":"Chem Eng J"},{"issue":"1","key":"10462_CR65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1166\/jbn.2020.2871","volume":"16","author":"S Simonet","year":"2020","unstructured":"Simonet S, Rodriguez-Lafrasse C, Beal D, Gerbaud S, Malesys C, Tillement O, Lux F, Fayyad-Kazan H, Rachidi W, Ardail D (2020) Gadolinium-based nanoparticles can overcome the radioresistance of head and neck squamous cell carcinoma through the induction of autophagy. J Biomed Nanotechnol 16(1):111\u2013124","journal-title":"J Biomed Nanotechnol"},{"key":"10462_CR66","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.phymed.2018.11.007","volume":"56","author":"H Li","year":"2019","unstructured":"Li H, Li X, Shi X, Li Z, Sun Y (2019) Effects of magnetic dihydroartemisinin nano-liposome in inhibiting the proliferation of head and neck squamous cell carcinomas. Phytomedicine 56:215\u2013228","journal-title":"Phytomedicine"},{"issue":"10","key":"10462_CR67","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.3390\/cells10102633","volume":"10","author":"VB Kumar","year":"2021","unstructured":"Kumar VB, Hsieh M-J, Mahalakshmi B, Chuang Y-C, Lin C-C, Lo Y-S, Ho H-Y, Lin J-T (2021) 7-Epitaxol induces apoptosis and autophagy in head and neck squamous cell carcinoma through inhibition of the ERK pathway. Cells 10(10):2633","journal-title":"Cells"},{"key":"10462_CR68","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s13402-019-00440-4","volume":"42","author":"R Kleszcz","year":"2019","unstructured":"Kleszcz R, Szyma\u0144ska A, Krajka-Ku\u017aniak V, Baer-Dubowska W, Paluszczak J (2019) Inhibition of CBP\/\u03b2-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells. Cell Oncol 42:505\u2013520","journal-title":"Cell Oncol"},{"issue":"18","key":"10462_CR69","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.3390\/ijms21186873","volume":"21","author":"HY Cho","year":"2020","unstructured":"Cho HY, Lee SW, Jeon YH, Lee DH, Kim GW, Yoo J, Kim SY, Kwon SH (2020) Combination of ACY-241 and JQ1 synergistically suppresses metastasis of HNSCC via regulation of MMP-2 and MMP-9. Int J Mol Sci 21(18):6873","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10462_CR70","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41419-021-03760-2","volume":"12","author":"X Xu","year":"2021","unstructured":"Xu X, Chen J, Li Y, Yang X, Wang Q, Wen Y, Yan M, Zhang J, Xu Q, Wei Y (2021) Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma. Cell Death Dis 12(5):482","journal-title":"Cell Death Dis"},{"issue":"10","key":"10462_CR71","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41419-020-03057-w","volume":"11","author":"LM Zhang","year":"2020","unstructured":"Zhang LM, Su LX, Hu JZ, Wang DM, Ju HY, Li X, Han YF, Xia WY, Guo W, Ren GX (2020) Epigenetic regulation of VENTXP1 suppresses tumor proliferation via miR-205-5p\/ANKRD2\/NF-kB signaling in head and neck squamous cell carcinoma. Cell Death Dis 11(10):838","journal-title":"Cell Death Dis"},{"issue":"1","key":"10462_CR72","doi-asserted-by":"crossref","first-page":"11231","DOI":"10.1038\/s41598-019-47755-8","volume":"9","author":"EK Kim","year":"2019","unstructured":"Kim EK, Cho YA (2019) Seo M-k, Ryu H, Cho BC, Koh YW, Yoon SO: NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma. Sci Rep 9(1):11231","journal-title":"Sci Rep"},{"issue":"5","key":"10462_CR73","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/cbdd.13166","volume":"91","author":"A Daei Farshchi Adli","year":"2017","unstructured":"Daei Farshchi Adli A, Jahanban-Esfahlan R, Seidi K, Samandari-Rad S, Zarghami N (2017) An overview on Vadimezan (DMXAA), the vascular disrupting agent. Chem Biol Drug Des 91(5):996\u20131006","journal-title":"Chem Biol Drug Des"},{"issue":"4","key":"10462_CR74","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1002\/jcp.26051","volume":"233","author":"R Jahanban-Esfahlan","year":"2017","unstructured":"Jahanban-Esfahlan R, Seidi K, Banimohamad-Shotorbani B, Jahanban-Esfahlan A, Yousefi B (2017) Combination of nanotechnology with vascular targeting agents for effective cancer therapy. J Cell Physiol 233(4):2982\u20132992","journal-title":"J Cell Physiol"},{"issue":"3","key":"10462_CR75","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12185-016-2171-3","volume":"105","author":"R Jahanban-Esfahlan","year":"2017","unstructured":"Jahanban-Esfahlan R, Seidi K, Zarghami N (2017) Tumor vascular infarction: prospects and challenges. Int J Hematol 105(3):244\u2013256","journal-title":"Int J Hematol"},{"issue":"3","key":"10462_CR76","doi-asserted-by":"crossref","first-page":"101042831769100","DOI":"10.1177\/1010428317691001","volume":"39","author":"K Seidi","year":"2017","unstructured":"Seidi K, Jahanban-Esfahlan R, Zarghami N (2017) Tumor rim cells: from resistance to vascular targeting agents to complete tumor ablation. Tumour Biol 39(3):1010428317691001","journal-title":"Tumour Biol"},{"key":"10462_CR77","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4137\/BCBCR.S7707","volume":"5","author":"RJ Esfahlan","year":"2011","unstructured":"Esfahlan RJ, Zarghami N, Esfahlan AJ, Mollazadeh M, Nejati K, Nasiri M (2011) The possible impact of obesity on androgen, progesterone and estrogen receptors (ERalpha and ERbeta) gene expression in breast cancer patients. Breast Cancer (Auckl) 5:227\u2013237","journal-title":"Breast Cancer (Auckl)"},{"key":"10462_CR78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109257","volume":"113","author":"R Pradhan","year":"2023","unstructured":"Pradhan R, Paul S, Das B, Sinha S, Dash SR, Mandal M, Kundu CN (2023) Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12\/IL-6-dependent pathway. J Nutr Biochem 113:109257","journal-title":"J Nutr Biochem"},{"issue":"8","key":"10462_CR79","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1007\/s11033-021-06610-8","volume":"48","author":"K Mohankumar","year":"2021","unstructured":"Mohankumar K, Francis AP, Pajaniradje S, Rajagopalan R (2021) Synthetic curcumin analog: inhibiting the invasion, angiogenesis, and metastasis in human laryngeal carcinoma cells via NF-kB pathway. Mol Biol Rep 48(8):6065\u20136074","journal-title":"Mol Biol Rep"},{"key":"10462_CR80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.18632\/oncotarget.28355","volume":"14","author":"MM Alam","year":"2023","unstructured":"Alam MM, Fermin JM, Knackstedt M, Noonan MJ, Powell T, Goodreau L, Daniel EK, Rong X, Moore-Medlin T, Khandelwal AR (2023) Everolimus downregulates STAT3\/HIF-1\u03b1\/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC). Oncotarget 14:85","journal-title":"Oncotarget"},{"key":"10462_CR81","doi-asserted-by":"crossref","unstructured":"Huang F, Qi H (2022) MiR-29c-3p\/C1QTNF6 restrains the angiogenesis and cell proliferation, migration and invasion in head and neck squamous cell carcinoma. Mol Biotechnol 1\u20139","DOI":"10.1007\/s12033-022-00591-0"},{"key":"10462_CR82","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dnarep.2018.04.002","volume":"66\u201367","author":"M Majidinia","year":"2018","unstructured":"Majidinia M, Darband SG, Kaviani M, Nabavi SM, Jahanban-Esfahlan R, Yousefi B (2018) Cross-regulation between Notch signaling pathway and miRNA machinery in cancer. DNA Repair (Amst) 66\u201367:30\u201341","journal-title":"DNA Repair (Amst)"},{"key":"10462_CR83","first-page":"096368972210835","volume":"31","author":"Z Wang","year":"2022","unstructured":"Wang Z, Jiao P, Zhong Y, Ji H, Zhang Y, Song H, Du H, Ding X, Wu H (2022) The endoplasmic reticulum-stressed head and neck squamous cell carcinoma cells induced exosomal miR-424-5p inhibits angiogenesis and migration of humanumbilical vein endothelial cells through LAMC1-mediated Wnt\/\u03b2-catenin signaling pathway. Cell Transpl 31:09636897221083549","journal-title":"Cell Transpl"},{"issue":"9","key":"10462_CR84","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jop.13050","volume":"49","author":"X Lu","year":"2020","unstructured":"Lu X, Wang Z, Huang H, Wang H (2020) Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma. J Oral Pathol Med 49(9):897\u2013906","journal-title":"J Oral Pathol Med"},{"key":"10462_CR85","doi-asserted-by":"crossref","unstructured":"Kim MS, Yang SH, Kim MS (2023) Role of ABCA2 and its single nucleotide polymorphisms (4873T>A and 4879G>C) in the regulation of multi-drug resistance in oral squamous carcinoma cells. Biochem Biophys Res Commun 2023.","DOI":"10.1016\/j.bbrc.2023.05.021"},{"key":"10462_CR86","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jconrel.2022.12.009","volume":"353","author":"M Shahpouri","year":"2023","unstructured":"Shahpouri M, Adili-Aghdam MA, Mahmudi H, Jaymand M, Amoozgar Z, Akbari M, Hamblin MR, Jahanban-Esfahlan R (2023) Prospects for hypoxia-based drug delivery platforms for the elimination of advanced metastatic tumors: from 3D modeling to clinical concepts. J Control Release 353:1002\u20131022","journal-title":"J Control Release"},{"key":"10462_CR87","doi-asserted-by":"crossref","unstructured":"Song C, Tang C, Xu W, Ran J, Wei Z, Wang Y, Zou H, Cheng W, Cai Y, Han W (2020) Hypoxia-targeting multifunctional nanoparticles for sensitized chemotherapy and phototherapy in head and neck squamous cell carcinoma. Int J Nanomed 347\u2013361","DOI":"10.2147\/IJN.S233294"},{"issue":"39","key":"10462_CR88","doi-asserted-by":"crossref","first-page":"44039","DOI":"10.1021\/acsami.2c10021","volume":"14","author":"Y Tao","year":"2022","unstructured":"Tao Y, Liu Y, Dong Z, Chen X, Wang Y, Li T, Li J, Zang S, He X, Chen D (2022) Cellular hypoxia mitigation by dandelion-like nanoparticles for synergistic photodynamic therapy of oral squamous cell carcinoma. ACS Appl Mater Interfaces 14(39):44039\u201344053","journal-title":"ACS Appl Mater Interfaces"},{"key":"10462_CR89","volume":"289","author":"J-Y Zhou","year":"2022","unstructured":"Zhou J-Y, Wang W-J, Zhang C-Y, Ling Y-Y, Hong X-J, Su Q, Li W-G, Mao Z-W, Cheng B, Tan C-P et al (2022) Ru(II)-modified TiO2 nanoparticles for hypoxia-adaptive photo-immunotherapy of oral squamous cell carcinoma. Biomaterials 289:121757","journal-title":"Biomaterials"},{"issue":"4","key":"10462_CR90","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/pharmaceutics15041166","volume":"15","author":"JS de Maar","year":"2023","unstructured":"de Maar JS, Zandvliet MM, Veraa S, Tob\u00f3n Restrepo M, Moonen CT, Deckers R (2023) Ultrasound and microbubbles mediated bleomycin delivery in feline oral squamous cell carcinoma\u2014an in vivo veterinary study. Pharmaceutics 15(4):1166","journal-title":"Pharmaceutics"},{"key":"10462_CR91","volume":"36","author":"J Wang","year":"2021","unstructured":"Wang J, Wang K, Liang J, Jin J, Wang X, Yan S (2021) Chitosan-tripolyphosphate nanoparticles-mediated co-delivery of MTHFD1L shRNA and 5-aminolevulinic acid for combination photodynamic-gene therapy in oral cancer. Photodiagn Photodyn Ther 36:102581","journal-title":"Photodiagn Photodyn Ther"},{"issue":"5","key":"10462_CR92","first-page":"5155","volume":"18","author":"N Matic","year":"2019","unstructured":"Matic N, Ressner M, Wiechec E, Roberg K (2019) In vitro measurement of glucose uptake after radiation and cetuximab treatment in head and neck cancer cell lines using 18F-FDG, gamma spectrometry and PET\/CT. Oncol Lett 18(5):5155\u20135162","journal-title":"Oncol Lett"},{"issue":"4","key":"10462_CR93","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.21037\/tcr.2019.07.50","volume":"8","author":"Y Huang","year":"2019","unstructured":"Huang Y, Xu J, Xu Y, Li L, Zheng M (2019) CD147 promotes glucose metabolism, invasion and metastasis via PI3K\/AKT pathway in oral squamous cell carcinomas. Transl Cancer Res 8(4):1486","journal-title":"Transl Cancer Res"},{"key":"10462_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01803-8","volume":"40","author":"L Lang","year":"2021","unstructured":"Lang L, Wang F, Ding Z, Zhao X, Loveless R, Xie J, Shay C, Qiu P, Ke Y, Saba NF (2021) Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer. J Exp Clin Cancer Res 40:1\u201314","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"10462_CR95","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.34049","volume":"151","author":"Y Tian","year":"2022","unstructured":"Tian Y, Tang C, Shi G, Wang G, Du Y, Tian J, Zhang H (2022) Novel fluorescent GLUT1 inhibitor for precision detection and fluorescence image-guided surgery in oral squamous cell carcinoma. Int J Cancer 151(3):450\u2013462","journal-title":"Int J Cancer"},{"key":"10462_CR96","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.2147\/CMAR.S255687","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Tang K, Chen L, Du M, Qu Z (2020) Exosomal circGDI2 suppresses oral squamous cell carcinoma progression through the regulation of miR-424-5p\/SCAI axis. Cancer Manag Res 12:7501","journal-title":"Cancer Manag Res"},{"issue":"4","key":"10462_CR97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2020.11941","volume":"20","author":"K Chang","year":"2020","unstructured":"Chang K, Wei Z, Cao H (2020) miR-375-3p inhibits the progression of laryngeal squamous cell carcinoma by targeting hepatocyte nuclear factor-1\u03b2. Oncol Lett 20(4):1\u20131","journal-title":"Oncol Lett"},{"issue":"1","key":"10462_CR98","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s12274-022-4811-7","volume":"16","author":"J-J Zhou","year":"2023","unstructured":"Zhou J-J, Li X-H, He P-Y, Qi F-Y, Ullah MW, Li S-J, Liu Y-T, Bu L-L, Yang G, Sun Z-J (2023) Implantable versatile oxidized bacterial cellulose membrane for postoperative HNSCC treatment via photothermal-boosted immunotherapy. Nano Res 16(1):951\u2013963","journal-title":"Nano Res"},{"key":"10462_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-020-00755-7","volume":"19","author":"L-L Bu","year":"2021","unstructured":"Bu L-L, Wang H-Q, Pan Y, Chen L, Wu H, Wu X, Zhao C, Rao L, Liu B, Sun Z-J (2021) Gelatinase-sensitive nanoparticles loaded with photosensitizer and STAT3 inhibitor for cancer photothermal therapy and immunotherapy. J Nanobiotechnology 19:1\u201313","journal-title":"J Nanobiotechnology"},{"key":"10462_CR100","unstructured":"Hasibuzzaman M, He R, Khan IN, Sabharwal R, Salem AK, Simons\u2010Burnett AL (2022) Characterization of CPH (2022) SA microparticle\u2010based delivery of interleukin\u20101 alpha for cancer immunotherapy. Bioeng Transl Med e10465"},{"key":"10462_CR101","volume":"81","author":"AA Mabrouk","year":"2023","unstructured":"Mabrouk AA, El-Mezayen NS, Awaad AK, Tadros MI, El-Gazayerly ON, El-Refaie WM (2023) Novel celecoxib-loaded chitosan-fucoidan nanoparticles as potential immunotherapy for oral squamous cell carcinoma: mechanistic insights. J Drug Deliv Sci Technol 81:104228","journal-title":"J Drug Deliv Sci Technol"},{"key":"10462_CR102","doi-asserted-by":"crossref","first-page":"110225","DOI":"10.1016\/j.biopha.2020.110225","volume":"127","author":"L Liu","year":"2020","unstructured":"Liu L, Zhu H, Liao Y, Wu W, Liu L, Liu L, Wu Y, Sun F, Lin H-W (2020) Inhibition of Wnt\/\u03b2-catenin pathway reverses multi-drug resistance and EMT in Oct4+\/Nanog+ NSCLC cells. Biomed Pharmacother 127:110225","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10462_CR103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2022.11658","volume":"24","author":"K Murakami","year":"2022","unstructured":"Murakami K, Umemura N, Adachi M, Motoki M, Ohkoshi E (2022) ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells. Exp Ther Med 24(6):1\u20139","journal-title":"Exp Ther Med"},{"issue":"20","key":"10462_CR104","doi-asserted-by":"crossref","first-page":"11260","DOI":"10.3390\/ijms222011260","volume":"22","author":"W-T Hsueh","year":"2021","unstructured":"Hsueh W-T, Chen S-H, Chien C-H, Chou S-W, Chi P-I, Chu J-M, Chang K-Y (2021) SOD2 enhancement by long-term inhibition of the pi3k pathway confers multi-drug resistance and enhanced tumor-initiating features in head and neck cancer. Int J Mol Sci 22(20):11260","journal-title":"Int J Mol Sci"},{"issue":"22","key":"10462_CR105","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1042\/CS20220581","volume":"136","author":"X Wang","year":"2022","unstructured":"Wang X, Li Y, Pan M, Lu T, Wang M, Wang Z, Liu C, Hu G (2022) CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial\u2013mesenchymal transition via inhibiting MDM2. Clin Sci 136(22):1691\u20131710","journal-title":"Clin Sci"},{"issue":"9","key":"10462_CR106","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3390\/ph14090902","volume":"14","author":"T-H Bang","year":"2021","unstructured":"Bang T-H, Park B-S, Kang H-M, Kim J-H, Kim I-R (2021) Polydatin, a glycoside of resveratrol, induces apoptosis and inhibits metastasis oral squamous cell carcinoma cells in vitro. Pharmaceuticals 14(9):902","journal-title":"Pharmaceuticals"},{"key":"10462_CR107","volume":"10","author":"C Ma","year":"2020","unstructured":"Ma C, Shi T, Qu Z, Zhang A, Wu Z, Zhao H, Zhao H, Chen H (2020) CircRNA_ACAP2 suppresses EMT in head and neck squamous cell carcinoma by targeting the miR-21-5p\/STAT3 signaling axis. Front Oncol 10:583682","journal-title":"Front Oncol"},{"issue":"7","key":"10462_CR108","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/cas.15338","volume":"113","author":"X Luo","year":"2022","unstructured":"Luo X, Chen Y, Tang H, Wang H, Jiang E, Shao Z, Liu K, Zhou X, Shang Z (2022) Melatonin inhibits EMT and PD-L1 expression through the ERK1\/2\/FOSL1 pathway and regulates anti-tumor immunity in HNSCC. Cancer Sci 113(7):2232\u20132245","journal-title":"Cancer Sci"},{"issue":"5","key":"10462_CR109","first-page":"1165","volume":"55","author":"M Zhao","year":"2019","unstructured":"Zhao M, Hu X, Xu Y, Wu C, Chen J, Ren Y, Kong L, Sun S, Zhang L, Jin R (2019) Targeting of EZH2 inhibits epithelial-mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3\/VEGFR2 axis. Int J Oncol 55(5):1165\u20131175","journal-title":"Int J Oncol"},{"issue":"5","key":"10462_CR110","first-page":"1","volume":"24","author":"W Hu","year":"2021","unstructured":"Hu W, Zhao Y, Su L, Wu Z, Jiang W, Jiang X, Liu M (2021) Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR-26a-5p. Mol Med Rep 24(5):1\u201312","journal-title":"Mol Med Rep"},{"key":"10462_CR111","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2021.01.006","volume":"506","author":"G Zhu","year":"2021","unstructured":"Zhu G, Cao B, Liang X, Li L, Hao Y, Meng W, He C, Wang L, Li L (2021) Small extracellular vesicles containing miR-192\/215 mediate hypoxia-induced cancer-associated fibroblast development in head and neck squamous cell carcinoma. Cancer Lett 506:11\u201322","journal-title":"Cancer Lett"},{"key":"10462_CR112","volume":"11","author":"Y Xu","year":"2021","unstructured":"Xu Y, Jiang E, Shao Z, Shang Z (2021) LncRNA FENDRR in carcinoma-associated fibroblasts regulates the angiogenesis of oral squamous cell carcinoma through the PI3K\/AKT pathway. Front Oncol 11:616576","journal-title":"Front Oncol"},{"issue":"4","key":"10462_CR113","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/cas.15281","volume":"113","author":"B Wang","year":"2022","unstructured":"Wang B, Zhang S, Tong F, Wang Y, Wei L (2022) HPV+ HNSCC-derived exosomal miR-9-5p inhibits TGF-\u03b2 signaling-mediated fibroblast phenotypic transformation through NOX4. Cancer Sci 113(4):1475","journal-title":"Cancer Sci"},{"issue":"38","key":"10462_CR114","doi-asserted-by":"crossref","first-page":"19833","DOI":"10.1039\/D0NR04682E","volume":"12","author":"C Xia","year":"2020","unstructured":"Xia C, Pan J, Wang J, Pu Y, Zhang Q, Hu S, Hu Q, Wang Y (2020) Functional blockade of cancer-associated fibroblasts with ultrafine gold nanomaterials causes an unprecedented bystander antitumoral effect. Nanoscale 12(38):19833\u201319843","journal-title":"Nanoscale"},{"key":"10462_CR115","doi-asserted-by":"crossref","unstructured":"Zeng D, Ma Z, Zan X, Luo T, Wang X, Gao X, Fu X (2023) A folic acid-decorated nanoparticles loaded JQ1 for oral squamous cell carcinoma therapy. Chin Chem Lett 108433","DOI":"10.1016\/j.cclet.2023.108433"},{"issue":"1","key":"10462_CR116","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41368-023-00216-5","volume":"15","author":"G Yuan","year":"2023","unstructured":"Yuan G, Yang S, Yang S (2023) RGS12 represses oral squamous cell carcinoma by driving M1 polarization of tumor-associated macrophages via controlling ciliary MYCBP2\/KIF2A signaling. Int J Oral Sci 15(1):11","journal-title":"Int J Oral Sci"},{"key":"10462_CR117","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.2147\/OTT.S249046","volume":"13","author":"R Chen","year":"2020","unstructured":"Chen R, Lu X, Li Z, Sun Y, He Z, Li X (2020) Dihydroartemisinin prevents progression and metastasis of head and neck squamous cell carcinoma by inhibiting polarization of macrophages in tumor microenvironment. Onco Targets Ther 13:3375","journal-title":"Onco Targets Ther"},{"key":"10462_CR118","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108624","volume":"92","author":"R Pradhan","year":"2021","unstructured":"Pradhan R, Chatterjee S, Hembram KC, Sethy C, Mandal M, Kundu CN (2021) Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages. J Nutr Biochem 92:108624","journal-title":"J Nutr Biochem"},{"issue":"8","key":"10462_CR119","doi-asserted-by":"crossref","first-page":"e004832","DOI":"10.1136\/jitc-2022-004832","volume":"10","author":"H-Y Cheng","year":"2022","unstructured":"Cheng H-Y, Hsieh C-H, Lin P-H, Chen Y-T, Hsu DS-S, Tai S-K, Chu P-Y, Yang M-H (2022) Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance. J ImmunoTherapy Cancer 10(8):e004832","journal-title":"J ImmunoTherapy Cancer"},{"key":"10462_CR120","doi-asserted-by":"crossref","unstructured":"Amoozgar Z, Jaymand M, Jahanban-Esfahlan R (2023) Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients. Front Oncol 13","DOI":"10.3389\/fonc.2023.1226974"},{"key":"10462_CR121","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fcell.2020.00229","volume":"8","author":"M Emamalipour","year":"2020","unstructured":"Emamalipour M, Seidi K, Vahed S, Jahanban-Esfahlan A, Jaymand M, Majdi H, Amoozgar Z, Chitkushev L, Javaheri T, Jahanban-Esfahlan R et al (2020) Horizontal gene transfer: From evolutionary flexibility to disease progression. Front Cell Dev Biol 8:229","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10462_CR122","first-page":"233","volume":"11","author":"A Mehrgou","year":"2021","unstructured":"Mehrgou A, Ebadollahi S, Seidi K, Ayoubi-Joshaghani MH, Ahmadieh Yazdi A, Zare P, Jaymand M, Jahanban-Esfahlan R (2021) Roles of miRNAs in colorectal cancer: therapeutic implications and clinical opportunities. Adv Pharm Bull 11(2):233\u2013247","journal-title":"Adv Pharm Bull"},{"issue":"2","key":"10462_CR123","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1158\/2326-6066.CIR-22-0277","volume":"11","author":"B-L Xiao","year":"2023","unstructured":"Xiao B-L, Wang X-L, Xia H-F, Zhang L-Z, Wang K-M, Chen Z-K, Zhong Y-H, Jiang H-G, Zhou F-X, Wang W (2023) HRS Regulates small extracellular vesicle PD-L1 secretion and is associated with Anti\u2013PD-1 treatment efficacy. Cancer Immunol Res 11(2):228\u2013240","journal-title":"Cancer Immunol Res"},{"issue":"19","key":"10462_CR124","doi-asserted-by":"crossref","first-page":"9198","DOI":"10.7150\/thno.62455","volume":"11","author":"G Zhu","year":"2021","unstructured":"Zhu G, Wang L, Meng W, Lu S, Cao B, Liang X, He C, Hao Y, Du X, Wang X (2021) LOXL2-enriched small extracellular vesicles mediate hypoxia-induced premetastatic niche and indicates poor outcome of head and neck cancer. Theranostics 11(19):9198","journal-title":"Theranostics"},{"key":"10462_CR125","volume":"49","author":"N Sun","year":"2023","unstructured":"Sun N, Zhang C, Wang J, Yue X, Kim HY, Zhang RY, Liu H, Widjaja J, Tang H, Zhang TX et al (2023) Hierarchical integration of DNA nanostructures and NanoGold onto a microchip facilitates covalent chemistry-mediated purification of circulating tumor cells in head and neck squamous cell carcinoma. Nano Today 49:101786","journal-title":"Nano Today"},{"issue":"4","key":"10462_CR126","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/bit.27248","volume":"117","author":"MH Ayubi Joshagani","year":"2020","unstructured":"Ayubi Joshagani MH, Dianat-Moghadam H, Seidi K, Jahanban-Esfahlan A, Zare P, Jahanban-Esfahlan R (2020) Cell-free protein synthesis: the transition from batch reactions to minimal cells and microfluidic devices. Biotechnol Bioengin 117(4):1204\u20131229","journal-title":"Biotechnol Bioengin"},{"key":"10462_CR127","doi-asserted-by":"crossref","unstructured":"Alamolhoda SZ, Zarghami N, Kahroba H, Mehdipour A, Pourhassan-Moghaddam M, Jahanban-Esfahlan R, Milani M (2021) Isothermal amplification of nucleic acids coupled with nanotechnology and microfluidic platforms for detecting antimicrobial drug resistance and beyond. Adv Pharm Bull","DOI":"10.34172\/apb.2022.004"},{"issue":"1","key":"10462_CR128","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1038\/s41598-020-63055-y","volume":"10","author":"M Zavridou","year":"2020","unstructured":"Zavridou M, Mastoraki S, Strati A, Koutsodontis G, Klinakis A, Psyrri A, Lianidou E (2020) Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma. Sci Rep 10(1):6551","journal-title":"Sci Rep"},{"key":"10462_CR129","volume":"137","author":"S Ida","year":"2023","unstructured":"Ida S, Takahashi H, Tada H, Mito I, Matsuyama T, Chikamatsu K (2023) Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma. Oral Oncol 137:106296","journal-title":"Oral Oncol"},{"issue":"21","key":"10462_CR130","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.3390\/cancers13215519","volume":"13","author":"K Payne","year":"2021","unstructured":"Payne K, Brooks JM, Taylor GS, Batis N, Noyvert B, Pan Y, Nankivell P, Mehanna H (2021) Immediate sample fixation increases circulating tumour cell (CTC) capture and preserves phenotype in head and neck squamous cell carcinoma: towards a standardised approach to microfluidic CTC biomarker discovery. Cancers 13(21):5519","journal-title":"Cancers"},{"key":"10462_CR131","doi-asserted-by":"crossref","unstructured":"Flach S, Howarth K, Hackinger S, Pipinikas C, Ellis P, McLay K, Marsico G, Walz C, Reichel CA, Gires O (2022) Liquid biopsy for minimal residual disease detection in head and neck squamous cell carcinoma (LIONESS): a personalized cell-free tumor DNA analysis for patients with HNSCC. J Clin Oncol","DOI":"10.1016\/j.annonc.2022.07.808"},{"key":"10462_CR132","doi-asserted-by":"crossref","first-page":"S795","DOI":"10.1016\/j.annonc.2021.08.1294","volume":"32","author":"S Flach","year":"2021","unstructured":"Flach S, Howarth K, Hackinger S, Pipinikas C, McLay K, Marsico G, Walz C, Reichel C, Gires O, Canis M (2021) 884P Personalised circulating cell-free tumour DNA analysis for detection of minimal residual disease and recurrence in patients with head and neck squamous cell carcinoma. Ann Oncol 32:S795\u2013S796","journal-title":"Ann Oncol"},{"key":"10462_CR133","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2020.07.027","volume":"151","author":"FJ Hilke","year":"2020","unstructured":"Hilke FJ, Muyas F, Admard J, Kootz B, Nann D, Welz S, Rie\u00df O, Zips D, Ossowski S, Schroeder C (2020) Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy. Radiother Oncol 151:182\u2013189","journal-title":"Radiother Oncol"},{"issue":"5","key":"10462_CR134","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2021.12.108","volume":"112","author":"N Earland","year":"2022","unstructured":"Earland N, Ramirez RJ, Harris PK, Gerndt S, Xu Z, Hearn A, Szymanski J, Semenkovich N, Jasim S, Chaudhuri AA (2022) Detection of locoregional minimal residual disease immediately after surgery through multi-omic analysis of tumor-associated cell-free DNA in surgical drain fluid. Int J Radiat Oncol Biol Phys 112(5):e47","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10462_CR135","doi-asserted-by":"crossref","first-page":"0019","DOI":"10.34133\/cbsystems.0019","volume":"4","author":"M Ye","year":"2023","unstructured":"Ye M, Zhou Y, Zhao H, Wang X (2023) Magnetic microrobots with folate targeting for drug delivery. Cyborg Bionic Syst 4:0019","journal-title":"Cyborg Bionic Syst"},{"key":"10462_CR136","doi-asserted-by":"crossref","first-page":"0060","DOI":"10.34133\/cbsystems.0060","volume":"4","author":"X Liang","year":"2023","unstructured":"Liang X, Zhao Y, Liu D, Deng Y, Arai T, Kojima M, Liu X (2023) Magnetic microrobots fabricated by photopolymerization and assembly. Cyborg Bionic Syst 4:0060","journal-title":"Cyborg Bionic Syst"},{"key":"10462_CR137","doi-asserted-by":"crossref","unstructured":"Jing R, Jiang Z, Tang X (2024) Advances in millimeter-wave treatment and its biological effects development. Int J Mol Sci 25(16)","DOI":"10.3390\/ijms25168638"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10462-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10462-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10462-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:32:31Z","timestamp":1766853151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10462-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10462"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10462-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is approved by the Biomedical Research Ethical Committee of Tabriz University of Medical Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"369"}}